Matinas Biopharma Holdings Inc (MTNB)
AMEX
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -455.297 | -87.223 | -60.805 | -41.796 | -35.798 | -39.563 | -65.621 |
Return on Equity (%) | -614.791 | -111.751 | -74.389 | -48.025 | -40.747 | -47.115 | -82.107 |
Return on Invested Capital (%) | -299.53 | -112.649 | -77.93 | -50.291 | -42.731 | -55.443 | -85.686 |
Operating Margin (%) | -10562 | -12158.333 | -19303.333 | -14206.962 | -70554.545 | -658.626 | -2093.248 |
Net Profit Margin (%) | -21890.667 | -12490 | -20330 | -14708.861 | -71754.545 | -658.626 | -2093.248 |
Book Value Per Share | 0.068 | 0.104 | 0.151 | 0.278 | 0.223 | 0.149 | 0.069 |
Earnings Per Share | -0.352 | -0.132 | -0.112 | -0.116 | -0.109 | -0.097 | -0.106 |
Cash Per Share | 0.078 | 0.11 | 0.136 | 0.062 | 0.097 | 0.031 | 0.022 |
Working Capital Per Share | 0.061 | 0.09 | 0.164 | 0.29 | 0.216 | 0.139 | 0.059 |
Operating Profit Per Share | 0.002 | 0.001 | 0.001 | 0.001 | N/A | 0.015 | 0.005 |
EBIT Per Share | -0.17 | -0.129 | -0.106 | -0.112 | -0.108 | -0.097 | -0.106 |
EBITDA Per Share | -0.17 | -0.129 | -0.106 | -0.112 | -0.108 | -0.097 | -0.106 |
Free Cash Flow Per Share | -0.343 | -0.129 | -0.114 | -0.117 | -0.109 | -0.094 | -0.106 |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 93.37M | 113.29M | 163.16M | 200.11M | 216.27M | 217.27M | N/A |
Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Shares Outstanding | 216.87M | 217.27M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -503.011 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -503.011 | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 2.85M |
Price to Earnings Ratio | -0.12 |
Price to Sales Ratio | 2.6 |
Price to Cash Ratio | 0.6 |
Price to Book Ratio | 0.15 |
Dividend Yield | - |
Shares Outstanding | 5.09M |
Average Volume (1 week) | 71.13k |
Average Volume (1 Month) | 390.01k |
52 Week Change | -95.25% |
52 Week High | 21.50 |
52 Week Low | 0.50 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.